Home News About Us Contact Contributors Disclaimer Privacy Policy Help FAQ

Home
Search
Quick Search
Advanced
Fulltext
Browse
Collections
Persons
My eDoc
Session History
Login
Name:
Password:
Documentation
Help
Support Wiki
Direct access to
document ID:


          Institute: MPI für experimentelle Medizin     Collection: MBNS     Display Documents



  history
ID: 292150.0, MPI für experimentelle Medizin / MBNS
Overexpression of EagI potassium channels in clinical tumours
Authors:Hemmerlein, Bernhard; Weseloh, Rüdiger M.; Mello de Queiroz, Fernanda; Knötgen, Hendrik; Sanchez, Araceli; Rubio, María E.; Martin, Sabine; Schliephacke, Tessa; Jenke, Marc; Radzun, Heinz-Joachim; Stühmer, Walter; Pardo, Luis A.
Language:English
Date of Publication (YYYY-MM-DD):2006-10
Title of Journal:Molecular Cancer
Journal Abbrev.:Mol. Cancer
Volume:5
Sequence Number of Article:41
Review Status:Peer-review
Audience:Experts Only
Abstract / Description:Background: Certain types of potassium channels (known as Eag1, KCNHO1, Kv10.1) are associated with the production of tumours in patients and in animals. We have now studied the expression pattern of the Eag1 channel in a large range of normal and tumour tissues from different collections utilising molecular biological and immunohistochemical techniques. Results: The use of reverse transcription real-time PCR and specifically generated monoclonal anti-Eag1 antibodies showed that expression of the channel is normally limited to specific areas of the brain and to restricted cell populations throughout the body. Tumour samples, however, showed a significant overexpression of the channel with high frequency (up to 80% depending on the tissue source) regardless of the detection method (staining with either one of the antibodies, or detection of Eag1 RNA). Conclusion: Inhibition of Eag1 expression in tumour cell lines reduced cell proliferation. Eag1 may therefore represent a promising target for the tailored treatment of human tumours. Furthermore, as normal cells expressing Eag1 are either protected by the blood-brain barrier or represent the terminal stage of normal differentiation, Eag1 based therapies could produce only minor side effects.
Free Keywords:A-GO-GO; K+ CHANNELS; ESCHERICHIA-COLI; MELANOMA-CELLS; BREAST-CANCER; ION CHANNELS; EXPRESSION; ETHER; CLONING; HERG
External Publication Status:published
Document Type:Article
Communicated by:Walter Stühmer
Affiliations:MPI für experimentelle Medizin/MBNS
Relations:Has References-DOI:10.1186/1476-4598-5-41
Identifiers:ISSN:1476-4598 [ID No:1]
ISI:000241536800001 [ID No:2]
ISI:000241536800001 [ID No:3]
Full Text:
You have privileges to view the following file(s):
Hemmerlein_06.pdf  [1,00 Mb]   
 
The scope and number of records on eDoc is subject to the collection policies defined by each institute - see "info" button in the collection browse view.